115 related articles for article (PubMed ID: 19250221)
1. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.
Cusimano A; Foderà D; Lampiasi N; Azzolina A; Notarbartolo M; Giannitrapani L; D'Alessandro N; Montalto G; Cervello M
Ann N Y Acad Sci; 2009 Feb; 1155():300-8. PubMed ID: 19250221
[TBL] [Abstract][Full Text] [Related]
2. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Lampiasi N; Foderà D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M
Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 1999 Dec; 5(12):4005-12. PubMed ID: 10632332
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M
Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression in hepatocellular carcinoma.
Shiota G; Okubo M; Noumi T; Noguchi N; Oyama K; Takano Y; Yashima K; Kishimoto Y; Kawasaki H
Hepatogastroenterology; 1999; 46(25):407-12. PubMed ID: 10228831
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of E-prostanoid receptors in human hepatocellular carcinoma.
Breinig M; Rieker R; Eiteneuer E; Wertenbruch T; Haugg AM; Helmke BM; Schirmacher P; Kern MA
Int J Cancer; 2008 Feb; 122(3):547-57. PubMed ID: 17918156
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells.
Mayoral R; Fernández-Martínez A; Boscá L; Martín-Sanz P
Carcinogenesis; 2005 Apr; 26(4):753-61. PubMed ID: 15661807
[TBL] [Abstract][Full Text] [Related]
10. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
[TBL] [Abstract][Full Text] [Related]
11. PGE(2) receptors and synthesis in human gastric mucosa: perturbation in cancer.
Takafuji VA; Evans A; Lynch KR; Roche JK
Prostaglandins Leukot Essent Fatty Acids; 2002 Jan; 66(1):71-81. PubMed ID: 12051958
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
Han C; Michalopoulos GK; Wu T
J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
[TBL] [Abstract][Full Text] [Related]
13. Reduction of dihydrodiol dehydrogenase expression in resected hepatocellular carcinoma.
Yang MD; Wu CC; Chiou SH; Chiu CF; Lin TY; Chiang IP; Chow KC
Oncol Rep; 2003; 10(2):271-6. PubMed ID: 12579257
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T cells in tumors of patients with hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Jin J; Li XY; Zhou le D; Huo Z; Zhou JH; Chen W
Digestion; 2009; 79(3):169-76. PubMed ID: 19329856
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
Kim SH; Kim SH; Song YC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the prostaglandin E2/E-prostanoid 2 receptor signaling pathway in abscess formation in rat zymosan-induced pleurisy.
Inada T; Arai K; Kawamura M; Hatanaka K; Sato Y; Noshiro M; Harada Y
J Pharmacol Exp Ther; 2009 Dec; 331(3):860-70. PubMed ID: 19726696
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 in hepatocellular carcinoma.
Wu T
Cancer Treat Rev; 2006 Feb; 32(1):28-44. PubMed ID: 16337744
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
19. Localization of prostanoid receptors and cyclo-oxygenase enzymes in guinea pig and human cochlea.
Stjernschantz J; Wentzel P; Rask-Andersen H
Hear Res; 2004 Nov; 197(1-2):65-73. PubMed ID: 15504605
[TBL] [Abstract][Full Text] [Related]
20. In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice.
Cui W; Hu SX; Tang ZY; Hu KQ
Anticancer Drugs; 2008 Oct; 19(9):891-7. PubMed ID: 18766003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
